Blog
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
SThree: Total Voting Rights
SThree: Total Voting Rights
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Total Voting Rights
Rights and Issues Investment Trust PLC: Total Voting Rights
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Halfords Group PLC: Director/PDMR Shareholding
Halfords Group PLC: Director/PDMR Shareholding
DGAP-News: HELLA GmbH & Co. KGaA: Klaus Kühn resigns as Chairman of the Supervisory Board and as a member of HELLA’s Shareholders’ Committee
DGAP-News: HELLA GmbH & Co. KGaA: Klaus Kühn resigns as Chairman of the Supervisory Board and as a member of HELLA’s Shareholders’ Committee
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Resignations of the Chairman of the Supervisory Board and the Member of the Shareholders Committee of HELLA GmbH & Co. KGaA, Klaus Kühn
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Resignations of the Chairman of the Supervisory Board and the Member of the Shareholders Committee of HELLA GmbH & Co. KGaA, Klaus Kühn
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
DGAP-News: Vonovia SE: 260 apprentices and dual degree students are set to join Vonovia
DGAP-News: Vonovia SE: 260 apprentices and dual degree students are set to join Vonovia
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
Ergomed (ERGO): Sustained growth momentum in H122
Ergomed (ERGO): Sustained growth momentum in H122
Bloc Ventures: Demand for deep tech unhindered by downturn
Bloc Ventures: Demand for deep tech unhindered by downturn
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
Nordea Bank Abp: Repurchase of own shares on 29.07.2022
Nordea Bank Abp: Repurchase of own shares on 29.07.2022
DGAP-News: Wacker Neuson SE: Wacker Neuson SE secures long-term financing with new credit lines and increases its financing flexibility
DGAP-News: Wacker Neuson SE: Wacker Neuson SE secures long-term financing with new credit lines and increases its financing flexibility
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: Aurubis AG: Aurubis completes sale of four flat rolled products sites to KME
DGAP-News: Aurubis AG: Aurubis completes sale of four flat rolled products sites to KME
DGAP-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 23,800 cars in Pizzale and Oriolo, Italy
DGAP-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 23,800 cars in Pizzale and Oriolo, Italy
Holcim successfully closes SES insulation and roofing business acquisition
Holcim successfully closes SES insulation and roofing business acquisition
DGAP-News: Stabilus SE: Double-digit revenue and earnings growth in Q3 FY2022
DGAP-News: Stabilus SE: Double-digit revenue and earnings growth in Q3 FY2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022


